September marks the beginning of National Prostate Cancer Awareness Month in the United States.

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

Rates of prostate cancer screening shared decision-making (SDM) are very low in family medicine practices, according to a study published in the June issue of the Southern Medical Journal. Nicholas ...

Jeremy Clarkson’s bombshell cancer diagnosis has put a spotlight on prostate cancer, triggering a surge in awareness and men ...

Prostate cancer affects 1 in 8 men in the UK, making it one of the most common and impactful health challenges facing men ...

Local community invited to walk with Prostate Cymru from Aberdaron to Pwllheli to raise funds and awareness for prostate ...

A doctor says many patients arrive with thick folders of check-up reports after buying broad screening packages. The warning ...

Inspired by his prostate cancer diagnosis, Jan Juc local Marcus Lens is riding 2,000km across WA to break stigmas, raise ...

It's the most common major cancer in America, even though it affects only one sex. Lifetime odds of getting it are 1 in 6. Testing for it is controversial, and ...

CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...

A study reveals significant disparities in cancer screening rates among sexual and gender minorities, highlighting the need ...